Suppr超能文献

比较药房续药数据与化学药物依从性测试在评估安全网医院环境下药物不依从性的效果。

Comparison of Pharmacy Refill Data With Chemical Adherence Testing in Assessing Medication Nonadherence in a Safety Net Hospital Setting.

机构信息

Department of Internal Medicine Parkland Health & Hospital System Dallas TX.

Cardiology Division Parkland Health & Hospital System Dallas TX.

出版信息

J Am Heart Assoc. 2022 Oct 4;11(19):e027099. doi: 10.1161/JAHA.122.027099.

Abstract

Background Pharmacy fill data are a practical tool for assessing medication nonadherence. However, previous studies have not compared the accuracy of pharmacy fill data to measurement of plasma drug levels, or chemical adherence testing (CAT). Methods and Results We performed a cross-sectional study in patients with uncontrolled hypertension in outpatient clinics in a safety net health system. Plasma samples were obtained for measurement of common cardiovascular drugs, including calcium channel blockers, thiazide diuretics, beta blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and statins, using liquid chromatography mass spectrometry. Proportion of days covered (PDC), a method for tracking pharmacy fill data, was calculated via linkages with Surescripts, and its diagnostic test characteristics were compared with CAT. Among 77 patients with uncontrolled hypertension, 13 (17%) were nonadherent to at least 1 antihypertensive drug and 23 (37%) were nonadherent to statins by CAT. PDC was significantly lower in the nonadherent versus the adherent group by CAT only among patients prescribed an angiotensin-converting enzyme inhibitor/angiotensin receptor blocker or statin (all <0.05) but not in patients prescribed other drug classes. The sensitivity and specificity of PDC in detecting nonadherence to angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and statin drugs by CAT were 75% to 82% and 56% to 79%, respectively. The positive predictive value of PDC in detecting nonadherence was only 11% to 27% for antihypertensive drugs and 45% for statins. Conclusions PDC is useful in detecting nonadherence to angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and statins but has limited usefulness in detecting nonadherence to calcium channel blockers, beta blockers, or thiazide diuretics and has a low positive predictive value for all drug classes.

摘要

背景

药剂填充数据是评估药物不依从性的实用工具。然而,之前的研究尚未将药剂填充数据与血浆药物水平的测量或化学药物依从性测试(CAT)进行比较。

方法和结果

我们在安全网医疗系统的门诊诊所中对未控制的高血压患者进行了一项横断面研究。使用液相色谱-质谱法获得了包括钙通道阻滞剂、噻嗪类利尿剂、β受体阻滞剂、血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂和他汀类药物在内的常见心血管药物的血浆样本。通过与 Surescripts 的链接计算了用于跟踪药剂填充数据的天数覆盖比例(PDC),并比较了其诊断测试特征与 CAT。在 77 名未控制高血压患者中,有 13 名(17%)患者至少有 1 种抗高血压药物不依从,23 名(37%)患者根据 CAT 不依从他汀类药物。仅在服用血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂或他汀类药物的患者中,与 CAT 相比,不依从患者的 PDC 明显较低(所有<0.05),但在服用其他药物类别的患者中则不然。PDC 在检测 CAT 对血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂和他汀类药物不依从的敏感性和特异性分别为 75%至 82%和 56%至 79%。PDC 检测抗高血压药物和他汀类药物不依从的阳性预测值仅为 11%至 27%,而他汀类药物的阳性预测值为 45%。

结论

PDC 可用于检测血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂和他汀类药物的不依从性,但对钙通道阻滞剂、β受体阻滞剂或噻嗪类利尿剂的不依从性检测具有有限的作用,并且对所有药物类别均具有较低的阳性预测值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd1/9673714/824b1471beb4/JAH3-11-e027099-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验